| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A deep learning method for total-body dynamic PET imaging with dual-time-window protocols
|
Ding, Wenxiang
|
|
|
52 |
4 |
p. 1448-1459
|
article
|
| 2 |
Assessment of fully quantitative and simplified methods for analysis of [68Ga]Ga-FAPI-46 uptake in patients with pancreatobiliary cancer using LAFOV PET/CT
|
Palard-Novello, Xavier
|
|
|
52 |
4 |
p. 1472-1480
|
article
|
| 3 |
Association of objective subtle cognitive difficulties with amyloid-β and tau deposition compared to subjective cognitive decline
|
Mao, Xiaoxie
|
|
|
52 |
4 |
p. 1481-1495
|
article
|
| 4 |
Cardiovascular disease and radiopharmaceutical therapies– an underestimated risk?
|
Lassmann, Michael
|
|
|
52 |
4 |
p. 1246-1248
|
article
|
| 5 |
Comparison of clinical performance between late and standard total-body [68 Ga]Ga-PSMA-11 in biochemical recurrent prostate cancer
|
Chen, Qiaochu
|
|
|
52 |
4 |
p. 1249-1256
|
article
|
| 6 |
Correction To: Coronary artery calcium measurement on attenuation correction computed tomography using artificial intelligence: correlation with coronary flow capacity and prognosis
|
Cho, Sang-Geon
|
|
|
52 |
4 |
p. 1601
|
article
|
| 7 |
Correction to: Noradrenergic cardiac denervation is associated with gait velocity in Parkinson disease: a dual ligand PET study
|
Carli, G.
|
|
|
52 |
4 |
p. 1596-1599
|
article
|
| 8 |
Correction to: Preclinical SPECT and PET: Joint EANM and ESMI procedure guideline for implementing an efficient quality control programme
|
Vanhove, Christian
|
|
|
52 |
4 |
p. 1600
|
article
|
| 9 |
Cross-modality PET image synthesis for Parkinson’s Disease diagnosis: a leap from [18F]FDG to [11C]CFT
|
Shen, Zhenrong
|
|
|
52 |
4 |
p. 1566-1575
|
article
|
| 10 |
Distinguishing benign from malignant lesions with high [68 Ga]Ga-FAPI-04 uptake in oncology patients: Insights from dynamic total-body [68 Ga]Ga-FAPI-04 PET/CT
|
Chen, Ruohua
|
|
|
52 |
4 |
p. 1345-1353
|
article
|
| 11 |
Dual-energy x-ray absorptiometry (DXA) in practice: a clinical centre survey endorsed by the European Association of Nuclear Medicine (EANM)
|
Punda, Marija
|
|
|
52 |
4 |
p. 1237-1241
|
article
|
| 12 |
Effect of molar dose on the in vivo tissue biodistribution profile of FAP-targeted radioligand therapeutics
|
Galbiati, Andrea
|
|
|
52 |
4 |
p. 1399-1405
|
article
|
| 13 |
Evaluation of long axial field-of-view (LAFOV) PET/CT for post-treatment dosimetry in Yttrium-90 radioembolization of liver tumors: a comparative study with conventional SPECT imaging
|
Zeimpekis, Konstantinos G.
|
|
|
52 |
4 |
p. 1460-1471
|
article
|
| 14 |
Evaluation of the safety, biodistribution, dosimetry of [18F]AlF-NYM005 and initial experience in clear cell renal cell carcinoma: an interim analysis of a prospective trial
|
Yang, Liping
|
|
|
52 |
4 |
p. 1354-1369
|
article
|
| 15 |
Exploration of (R)-[11C]YH168 as a PET tracer for imaging monoacylglycerol lipase in the brain: from mice to non-human primates
|
He, Yingfang
|
|
|
52 |
4 |
p. 1556-1565
|
article
|
| 16 |
[18F]FDG PET/CT for predicting neoadjuvant PD-L1 blockade monotherapy treatment response in patients with locally advanced esophageal squamous cell carcinoma: a preliminary study
|
Yang, Runjun
|
|
|
52 |
4 |
p. 1422-1435
|
article
|
| 17 |
[68Ga]Ga-PSMA-617 PET/MRI for imaging patients suspected of hepatocellular carcinoma
|
Qin, Chunxia
|
|
|
52 |
4 |
p. 1278-1290
|
article
|
| 18 |
Human dose-escalation study of PET imaging CD8+ T-cell infiltration in solid malignancies with [68Ga]Ga -NODAGA-SNA006
|
Wang, Yan
|
|
|
52 |
4 |
p. 1332-1344
|
article
|
| 19 |
Incorporating label uncertainty during the training of convolutional neural networks improves performance for the discrimination between certain and inconclusive cases in dopamine transporter SPECT
|
Kucerenko, Aleksej
|
|
|
52 |
4 |
p. 1535-1548
|
article
|
| 20 |
Molecular imaging: The bridge from human phenome to personalized precision medicine
|
Tian, Mei
|
|
|
52 |
4 |
p. 1233-1236
|
article
|
| 21 |
Phase I study of [68Ga]Ga-HX01 for targeting integrin αvβ3 and CD13 in healthy and malignancy subjects
|
Zhang, Xiao
|
|
|
52 |
4 |
p. 1293-1304
|
article
|
| 22 |
Preclinical comparison of (radio)lanthanides using mass spectrometry and nuclear imaging techniques: biodistribution of lanthanide-based tumor-targeting agents and lanthanides in ionic form
|
Wallimann, Rahel H.
|
|
|
52 |
4 |
p. 1370-1382
|
article
|
| 23 |
Preclinical investigation of [149Tb]Tb-DOTATATE and [149Tb]Tb-DOTA-LM3 for tumor-targeted alpha therapy
|
Mapanao, Ana Katrina
|
|
|
52 |
4 |
p. 1383-1398
|
article
|
| 24 |
Preclinical safety and effectiveness of a long-acting somatostatin analogue [225Ac]Ac-EBTATE against small cell lung cancer and pancreatic neuroendocrine tumors
|
Njotu, Fabrice N.
|
|
|
52 |
4 |
p. 1305-1320
|
article
|
| 25 |
Presynaptic terminal integrity is associated with glucose metabolism in Parkinson’s disease
|
Wang, Weiyi
|
|
|
52 |
4 |
p. 1510-1519
|
article
|
| 26 |
PSMA-targeted radioligand therapy in metastatic prostate cancer: Comprehensive analysis of recent evidence
|
Petranović Ovčariček, Petra
|
|
|
52 |
4 |
p. 1242-1245
|
article
|
| 27 |
Radioiodinated Nanobody immunoPET probe for in vivo detection of CD147 in pan-cancer
|
Ma, Xiaokun
|
|
|
52 |
4 |
p. 1406-1421
|
article
|
| 28 |
Radiopharmaceutical formulation and preliminary clinical dosimetry of [177Lu]Lu-DOTA-MGS5 for application in peptide receptor radionuclide therapy
|
Zavvar, Taraneh Sadat
|
|
|
52 |
4 |
p. 1321-1331
|
article
|
| 29 |
Real-time diagnosis of sampled lesions in targeted biopsy of prostate Cancer using a novel tracer [64Cu] Cu-DOTA-PSMA-3Q: a pilot preclinical study
|
Zhang, Jingfeng
|
|
|
52 |
4 |
p. 1257-1270
|
article
|
| 30 |
Reliable diagnosis of nigrostriatal degeneration by dopamine transporter SPECT despite drug interaction with venlafaxine or bupropion
|
Apostolova, Ivayla
|
|
|
52 |
4 |
p. 1549-1555
|
article
|
| 31 |
Safety of PSMA radioligand therapy in mCRPC patients with preexisting moderate to severe thrombocytopenia
|
Bastian, Moritz B.
|
|
|
52 |
4 |
p. 1271-1277
|
article
|
| 32 |
Self-supervised neural network for Patlak-based parametric imaging in dynamic [18F]FDG total-body PET
|
Gu, Wenjian
|
|
|
52 |
4 |
p. 1436-1447
|
article
|
| 33 |
Subcortical tau deposition and plasma glial fibrillary acidic protein as predictors of cognitive decline in mild cognitive impairment and Alzheimer’s disease
|
Chang, Yan
|
|
|
52 |
4 |
p. 1496-1509
|
article
|
| 34 |
Systematic review: Mechanisms of photoactive nanocarriers for imaging and therapy including controlled drug delivery
|
Zhang, Yapei
|
|
|
52 |
4 |
p. 1576-1595
|
article
|
| 35 |
The cerebellar glucose metabolism in moyamoya vasculopathy and its correlation with neurocognitive performance after cerebral revascularization surgery: a [18F]FDG PET study
|
Weng, Ruiyuan
|
|
|
52 |
4 |
p. 1520-1534
|
article
|
| 36 |
αvβ6-integrin targeted [68Ga]Ga-Trivehexin PET/CT imaging of a rare bronchial mucoepidermoid carcinoma
|
Wu, Huiqin
|
|
|
52 |
4 |
p. 1291-1292
|
article
|
Journal description